Streetbeat News

Analyst Ratings

PIPR

JMP Securities analyst Trevor Walsh has reiterated a Market Outperform rating on Piper Sandler (NYSE:PIPR) and maintained a price target of $170.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:42 pm

EPR

JMP Securities analyst Mitch Germain maintains a Market Outperform rating on EPR Properties (NYSE:EPR) but lowers the price target from $54 to $48.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:41 pm

NVT

RBC Capital analyst Deane Dray has maintained an 'Outperform' rating on nVent Electric (NYSE:NVT) but lowered the price target from $60 to $57.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:37 pm

CSCO

Raymond James analyst Simon Leopold has downgraded Cisco Systems Inc (NASDAQ:CSCO) to Market Perform from Outperform, citing concerns over declining campus application sales and the pending $28 billion Splunk acquisition. The analyst anticipates a worse-than-seasonal sales decline in Cisco's January quarter and sees restrained IT spending due to a sluggish macroeconomic environment and higher interest rates. However, he sees AI as an emerging tailwind for the company's multi-year growth.

Portfolio Pulse from Lekha Gupta

October 30, 2023 | 6:37 pm

UDR

RBC Capital analyst Brad Heffern maintains a Sector Perform rating on UDR (NYSE:UDR) and lowers the price target from $39 to $37.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:36 pm

CC

RBC Capital analyst Arun Viswanathan maintains a 'Sector Perform' rating on Chemours (NYSE:CC) and lowers the price target from $30 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:34 pm

NOVA

RBC Capital analyst Elvira Scotto maintains an 'Outperform' rating on Sunnova Energy Intl (NYSE:NOVA) but lowers the price target from $20 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:33 pm

PFS

RBC Capital analyst Jon Arfstrom has maintained an 'Outperform' rating on Provident Financial Services (PFS), but lowered the price target from $19 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:31 pm

BMY

A significant bearish stance has been taken on Bristol-Myers Squibb (NYSE:BMY) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 75% bearish and 25% bullish. The whales have been targeting a price range from $30.0 to $57.5 for Bristol-Myers Squibb over the last 3 months. The price of BMY is currently up 1.18% at $51.62.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 6:30 pm

NWL

RBC Capital analyst Nik Modi has maintained a 'Sector Perform' rating on Newell Brands (NASDAQ:NWL) but lowered the price target from $12 to $9.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 6:30 pm